The preclinical data generated by agents produced by the GLP practice can be valuable in the later development of clinical trials in gene therapy. To help investigators choose the optimum vector ...
“We have seen remarkable results from clinical trials using AAV vectors for AADC gene transfer,” says Shin-ichi Muramatsu, a pioneer of AAV vector research, and a professor in Jichi Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback